Avedro Heads Back to the FDA

posted Oct 6, 2014, 5:49 PM by Jen Weigel
Earlier this year, the FDA's judgement on Avedro's accelerated corneal crosslinking procedure for the treatment keratoconus and post-LASIK ectasia said that the FDA required more information prior to approving this procedure.

On September 30, 2014, Avedro resubmitted it's New Drug Application to the FDA.  Keep your fingers crossed for a positive response from the FDA come March 2015.